17:14:42 Europe / Stockholm

Bifogade filer

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2024-11-06 Kvartalsrapport 2024-Q3
2024-08-16 Kvartalsrapport 2024-Q2
2024-05-16 X-dag ordinarie utdelning AMBEA 1.50 SEK
2024-05-15 Årsstämma 2024
2024-05-03 Kvartalsrapport 2024-Q1
2024-02-08 Bokslutskommuniké 2023
2023-11-02 Kvartalsrapport 2023-Q3
2023-08-17 Kvartalsrapport 2023-Q2
2023-05-12 X-dag ordinarie utdelning AMBEA 1.25 SEK
2023-05-11 Årsstämma 2023
2023-05-04 Kvartalsrapport 2023-Q1
2023-02-09 Bokslutskommuniké 2022
2022-11-03 Kvartalsrapport 2022-Q3
2022-08-18 Kvartalsrapport 2022-Q2
2022-05-13 X-dag ordinarie utdelning AMBEA 1.15 SEK
2022-05-12 Årsstämma 2022
2022-05-04 Kvartalsrapport 2022-Q1
2022-02-09 Bokslutskommuniké 2021
2021-11-04 Kvartalsrapport 2021-Q3
2021-07-23 Kvartalsrapport 2021-Q2
2021-05-14 X-dag ordinarie utdelning AMBEA 1.15 SEK
2021-05-12 Årsstämma 2021
2021-05-04 Kvartalsrapport 2021-Q1
2021-02-16 Bokslutskommuniké 2020
2020-11-05 Kvartalsrapport 2020-Q3
2020-08-19 Kvartalsrapport 2020-Q2
2020-05-18 X-dag ordinarie utdelning AMBEA 0.00 SEK
2020-05-15 Årsstämma 2020
2020-05-13 Kvartalsrapport 2020-Q1
2020-02-14 Bokslutskommuniké 2019
2019-11-08 Kvartalsrapport 2019-Q3
2019-08-20 Kvartalsrapport 2019-Q2
2019-05-17 X-dag ordinarie utdelning AMBEA 1.10 SEK
2019-05-16 Årsstämma 2019
2019-05-10 Kvartalsrapport 2019-Q1
2019-02-13 Bokslutskommuniké 2018
2018-11-13 Kvartalsrapport 2018-Q3
2018-08-21 Kvartalsrapport 2018-Q2
2018-05-24 X-dag ordinarie utdelning AMBEA 1.00 SEK
2018-05-23 Årsstämma 2018
2018-05-17 Kvartalsrapport 2018-Q1
2018-02-21 Bokslutskommuniké 2017
2017-11-17 Kvartalsrapport 2017-Q3
2017-08-17 Kvartalsrapport 2017-Q2
2017-05-17 Kvartalsrapport 2017-Q1

Beskrivning

LandSverige
ListaMid Cap Stockholm
SektorHälsovård
IndustriVård & Omsorg
Ambea är verksamma inom vård och omsorg. Bolaget erbjuder tjänster och bemanning relaterade till funktionsnedsättning, individ- och familjeomsorg, samt äldreomsorg via boenden och egen regi. Bemanningsstyrkan består exempelvis av specialiserade läkare, sjuksköterskor, lärare och socionomer. Ambea har för närvarande verksamhet runtom den nordiska marknaden, med huvudkontor i Solna.
2023-02-09 09:04:03

The correction refers to missing the word adjusted in the bullet points four in the summary of the fourth quarter (October - December) and full year (January - December) 2022. The correction only applies to the English version.

Corrected press release and year-end report follows in its entirety.

CEO comment:

Strong organic growth continued in the fourth quarter, and our Swedish divisions, Nytida and Vardaga, showed stable underlying earnings, while the strategic shift in Klara generated results.

Klara is now making a greater contribution to consolidated earnings, which was evident during the quarter. During the quarter, we were generally impacted by higher costs for electricity, food and consumables. Sick leave also increased across our units. In Altiden, we worked intensively with integration and change management. The quarterly earnings were charged with non-recurring, reorganization related costs to create a stronger and more stable operation. Operational improvements and lower administration costs in Altiden enable gradual performance improvements in 2023.

Higher sales and a share buyback
In the fourth quarter, net sales rose 8 per cent to SEK 3,225 million (2,988). Adjusted EBITA was SEK 170 million (214), corresponding to a margin of 5.3 per cent (7.2). Due to the company's strong cash flow and financial position, Ambea's Board decided on a share buyback in November to optimise the company's capital structure and increase shareholder value. The share buyback programme to purchase up to 5 million shares is ongoing.

Fourth quarter October-December
  • Net sales rose 8 per cent to SEK 3,225 million (2,988). Organic growth was 4 per cent, acquired growth was 2 per cent and the exchange rate effect was 2 per cent.
  • Operating profit (EBIT) totalled SEK 140 million (37).
  • EBITA increased 146 per cent to SEK 170 million (69), corresponding to a margin of 5.3 per cent (2.3)
  • Adjusted EBITA declined 21 per cent to SEK 170 million (214), representing a margin of 5.3 per cent (7.2).
  • Profit for the period totalled SEK 22 million (loss: -37).
  • Earnings per share were SEK 0.24 (loss: -0.39) before and after dilution.
  • Cash conversion was 121.3 per cent (148.1).
  • Free cash flow totalled SEK 402 million (410).
Full-year January-December
  • Net sales rose 10 per cent to SEK 12,635 million (11,478). Organic growth was 5 per cent, acquired growth was 3 per cent and exchange rates had a 2 per cent impact on growth.
  • Operating profit (EBIT) totalled SEK 843 million (598).
  • EBITA rose 34 per cent to SEK 954 million (712), representing a margin of 7.6 per cent (6.2).
  • Adjusted EBITA rose 11 per cent to SEK 954 million (857), representing a margin of 7.6 per cent (7.5).
  • Profit for the year totalled SEK 366 million (237).
  • Earnings per share were SEK 3.89 (2.51) before and after dilution.
  • Cash conversion was 95.6 per cent (95.7).
  • Free cash flow totalled SEK 1,451 million (1,139).
  • The Board proposes a dividend of SEK 1.25 (1.15) per share for 2022

Telephone conference
In connection to the announcement, Ambea will host a telephone conference today at 10:00 (CET). The presentation will be held in English and available as webcast on www.ambea.com or direct link: https://edge.media-server.com/mmc/p/8nqfj93c

To participate the conference call, register before the call using the link below. Upon registration you will receive a dial-in number and a unique personal PIN code. To ensure that the connection to the conference call is working, please dial in ten minutes before the start time of the conference call.

Telephone conference registration:
https://register.vevent.com/register/BI2801f8a9f212465dbbcdd9b1164cda11

The quarterly earnings report and associated presentation will be available on www.ambea.com

This disclosure contains information that Ambea is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014) and the Swedish Securities Markets Act (2007:528). The information was submitted for publication, through the agency of the contact person, on 09-02-2023 09:04 CET.